Pharmaceutical

Charles River partners with Magellan Stem Cells on cell...

The partnership focuses on biologics quality control as well as viral and releas...

Pfizer partners with Enodia Therapeutics in $500m drug ...

Under the partnership, Enodia Therapeutics will handle initial discovery work to...

From botox to algorithms: How AI is redefining cosmetic...

Dr Ashok Patel, Aesthetic Surgeon, Founder and Chief Medical Officer, Brillianc...

NIPER Raebareli, AstraZeneca India partner to expand cl...

The collaboration will assess and support 25 clinical trial sites across emergi...

ISCR, CHAKRA sign MoU to strengthen clinical research c...

The partnership will focus on GCP and ethics training, research governance, qua...

Biocon secures global settlement with Genentech for Peb...

The agreement sets licensed launch dates for Biocon’s pertuzumab biosimilar in ...

Godavari Biorefineries secures Mexican patent for antiv...

The patent covers compounds that inhibit V-ATPase and their use in the manufact...

China’s NMPA clears Foresee’s Camcevi 42 mg for prostat...

The company was informed of the decision by its domestic licensing partner, Chan...

Southern Research secures NIH funding for drug testing hub

The planned facility will focus on the development, validation, and adoption of ...

India’s biotech innovation may be hidden in its biodive...

Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project Inter...

India’s biotech growth story is now a manufacturing sto...

As production becomes more complex and highly regulated, digitalisation and aut...

Dermatology meets aesthetics: Why the boundary between ...

The relationship between dermatology and aesthetic medicine is one of the most ...

NuSynth to build chemical process innovation platform w...

The company will use the capital to develop its R&D and technology capabilities...

Zydus, Formycon’s Keytruda biosimilar FYB206 accepted f...

The BLA was submitted in Q3 2026, with a regulatory decision potentially expect...

FDA approves Asahi Kasei’s Hovilpri for refractory HSV

This oral medication is indicated for patients whose infections do not respond, ...

Perceptive, Nucleus partner to support radiopharmaceuti...

Under the terms of the agreement, the two companies will direct qualified custom...